JPS5328181A - Production of nove substituted 2*33alkylenebis *oxy* benzoic acid - Google Patents

Production of nove substituted 2*33alkylenebis *oxy* benzoic acid

Info

Publication number
JPS5328181A
JPS5328181A JP9405777A JP9405777A JPS5328181A JP S5328181 A JPS5328181 A JP S5328181A JP 9405777 A JP9405777 A JP 9405777A JP 9405777 A JP9405777 A JP 9405777A JP S5328181 A JPS5328181 A JP S5328181A
Authority
JP
Japan
Prior art keywords
substd
opt
alkyl
alkenyl
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9405777A
Other languages
Japanese (ja)
Other versions
JPS5737594B2 (en
Inventor
Tomine Mishieru
Biyurutoo Jieraaru
Ashie Jiyatsuku
Koriniyon Kuroodo
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/en
Priority to GB44877/78A priority Critical patent/GB1571278A/en
Priority claimed from GB44877/78A external-priority patent/GB1571278A/en
Application filed by Ile De France filed Critical Ile De France
Priority to JP9405777A priority patent/JPS5328181A/en
Publication of JPS5328181A publication Critical patent/JPS5328181A/en
Publication of JPS5737594B2 publication Critical patent/JPS5737594B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

2,3-Alkylenedioxybenzamides of formula (I) and their acid -addn. salts, quat. ammonium salts, oxides and optical isomers are new. In (I), A is 1-3C alkylene opt. substd by 1-4C alkyl, 2-4C alkenyl or 1-4C hydroxyalkyl. R is H, 1-4C alkyl or -B-NR1R2; B is a direct bond or a 1-3C alkylene gp. opt. substd. by 1-4C alkyl or 2-4C alkenyl; R1 is H, 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl, substd. alkyl, or forms a heterocyclic ring with B, and R2 is H, 1-4C alkyl, 2-4C alkenyl or alkynyl, substd. alkyl, an opt. substd. heterocyclic gp., or a phenyl, adamantyl, cycloalkyl, bicycloalkyl or cycloalkenyl gp. bonded directly to the N atom or via an opt. substd. alkylene chain, or NR1R2 is a heterocycle opt. contg. other heteroatoms (including NR'', where R'' is H- 1-4C alkyl, 2-4C alkenyl or alkynyl, phenyl, benzyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, adamantyl, bicycloalkyl or alkyl substd by OH, SH, acyl, thioacyl, alkoxy or alkylthio). - R' is H, 1-4c alkyl, 2-4C alkenyl or alkynyl, adamantyl, pyrimidinyl, pyrazinyl, diazepinyl, quinuclidinyl, azabicycloalkyl, diazabicycloalkyl, bicycloalkyl, or opt. substd. phenyl or aralkyl, or R'+B forms an opt. substd. heterocycle contg. a single N atom, or R'+R1 forms an opt. substd. heterocycle contg. two heteroatoms, X is H, halogen, OH, 1-4C alkoxy, 1-4C alkyl, amino opt. mono- or disubstd. by 1-4C alkyl, acyl, aralkyl, furyl, pyranyl or alkoxycacarbonyl, or forms an A' chain with Y. Y is as defined for X or is NO2, 1-4C alkylsulphonyl, adamantyl-sulphonyl, cycloalkyl sulphonyl or SO2NR3R'; R3 and R4 are H, 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl, phenyl, benzyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, bicycloalkyl, adamantyl, pyrimidinyl, pyrazinyl, or alkyl substd. by OH, SH, acyl, thioacyl, alkoxy or alkylthio, or NR3R4 is an opt. substd. heterocycle opt. congt. another heteroatom; or Y forms an A chain with X or Z. Z is as defined for X or is NO2, or forms an A chain with Y. A is a carbon chain opt. substd. or opt. interrupted by one or more opt. substd. heteroatoms. - Cpds. (I) have anxiolytic, antidepressant and antiemetic activity with little or no cataleptic activity. A typical cpd. of N-(1-allyl-2-pyrrolidinylmethyl)-7-methylsulphamoyl-1, 4-benzodioxan-5-carboxamide. In an example, this is prepd. from 1,4-benzodioxan-5-carboxylic acid.
JP9405777A 1976-08-04 1977-08-04 Production of nove substituted 2*33alkylenebis *oxy* benzoic acid Granted JPS5328181A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB44877/78A GB1571278A (en) 1976-08-04 1977-08-01 2,3-alkylene bis(oxy)benzoic acids
JP9405777A JPS5328181A (en) 1976-08-04 1977-08-04 Production of nove substituted 2*33alkylenebis *oxy* benzoic acid

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (en) 1976-08-04 1976-08-04 NEW 2,3-ALKYLENE BIS (OXY) BENZAMIDE SUBSTITUTES, THEIR DERIVATIVES AND THEIR PREPARATION METHODS
GB44877/78A GB1571278A (en) 1976-08-04 1977-08-01 2,3-alkylene bis(oxy)benzoic acids
JP9405777A JPS5328181A (en) 1976-08-04 1977-08-04 Production of nove substituted 2*33alkylenebis *oxy* benzoic acid

Publications (2)

Publication Number Publication Date
JPS5328181A true JPS5328181A (en) 1978-03-16
JPS5737594B2 JPS5737594B2 (en) 1982-08-10

Family

ID=52850495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9405777A Granted JPS5328181A (en) 1976-08-04 1977-08-04 Production of nove substituted 2*33alkylenebis *oxy* benzoic acid

Country Status (1)

Country Link
JP (1) JPS5328181A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6069145A (en) * 1983-09-27 1985-04-19 Showa Denko Kk Thermoforming olefin polymer composition
JPH02289566A (en) * 1989-03-22 1990-11-29 Janssen Pharmaceut Nv N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin)carboxamide derivative

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6069145A (en) * 1983-09-27 1985-04-19 Showa Denko Kk Thermoforming olefin polymer composition
JPH0465853B2 (en) * 1983-09-27 1992-10-21 Showa Denko Kk
JPH02289566A (en) * 1989-03-22 1990-11-29 Janssen Pharmaceut Nv N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin)carboxamide derivative

Also Published As

Publication number Publication date
JPS5737594B2 (en) 1982-08-10

Similar Documents

Publication Publication Date Title
ES2061845T3 (en) A PROCEDURE FOR PREPARING A SPIRAL COMPOUND.
FR2396757A2 (en) Psycho-functional alkylene bis:oxy benzamide cpds. - useful in gastroenterology, cardiology, urology, rheumatology and gynaecology
BR8303898A (en) COMPOUNDS, PROCESS FOR THE MANUFACTURE OF THE SAME, MEDICINE AND USE OF SUCH COMPOUNDS
FR2360305B1 (en)
YU188277A (en) Process for obtaining new substituted 2,3-alkylene-bis-(oxy)-benzimides
JPS5328181A (en) Production of nove substituted 2*33alkylenebis *oxy* benzoic acid
ATE18203T1 (en) (-)-15-DEOXYSPERGUALIN, ITS MANUFACTURE AND MEDICATIONS CONTAINING THIS ACTIVE SUBSTANCE.
FR2421897A1 (en) Alpha substd. 3-thienyl:acetamide derivs. - useful as hypnotic, anticonvulsant and tranquillising agents
FR2323383A1 (en) (2)-Alkyl (5)-thiazole-methyl-amines - with antilipolytic and hypoglycaemic activity
FR2372628A2 (en) (2)-Alkyl (5)-thiazole-methyl-amines - with antilipolytic and hypoglycaemic activity
AR247563A1 (en) New pyridinilpyrimidine derivatives and a protector for illnesses of plants that contain them as an active ingredient